X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1621) 1621
Publication (200) 200
Conference Proceeding (81) 81
Newspaper Article (26) 26
Book Chapter (25) 25
Book / eBook (20) 20
Dissertation (19) 19
Paper (14) 14
Patent (13) 13
Web Resource (13) 13
Magazine Article (11) 11
Book Review (7) 7
Government Document (1) 1
Reference (1) 1
Report (1) 1
Technical Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (397) 397
index medicus (315) 315
male (282) 282
female (256) 256
animals (170) 170
middle aged (158) 158
adult (145) 145
analysis (140) 140
aged (125) 125
physics (94) 94
astrophysics (85) 85
research (77) 77
surgery (66) 66
cancer (58) 58
mice (57) 57
high energy astrophysical phenomena (55) 55
cell biology (51) 51
genetics & heredity (51) 51
physics, particles & fields (51) 51
biochemistry & molecular biology (50) 50
oncology (50) 50
adolescent (48) 48
rats (47) 47
expression (45) 45
sciences of the universe (45) 45
medicine & public health (44) 44
pharmacology & pharmacy (44) 44
treatment outcome (44) 44
mutation (43) 43
agriculture (42) 42
molecular sequence data (42) 42
risk factors (42) 42
italy (41) 41
aged, 80 and over (40) 40
astronomy & astrophysics (40) 40
medicine (40) 40
remote sensing (40) 40
chemistry, physical (39) 39
instruments & instrumentation (38) 38
neurosciences (38) 38
gene expression (37) 37
performance (37) 37
algorithms (36) 36
cosmic rays (36) 36
dna (36) 36
base sequence (35) 35
biology (35) 35
diagnosis (35) 35
genes (35) 35
genetic aspects (35) 35
materials science, multidisciplinary (35) 35
prognosis (35) 35
research article (34) 34
physics - high energy astrophysical phenomena (33) 33
prospective studies (33) 33
proteins (32) 32
young adult (32) 32
methods (31) 31
mortality (31) 31
multidisciplinary sciences (31) 31
time factors (31) 31
article (30) 30
life sciences (30) 30
models (30) 30
tumors (30) 30
activation (29) 29
biotechnology & applied microbiology (29) 29
immunology (29) 29
physiological aspects (29) 29
model (28) 28
astrophysics - high energy astrophysical phenomena (27) 27
care and treatment (27) 27
child (27) 27
identification (27) 27
management (27) 27
studies (27) 27
usage (27) 27
cardiac & cardiovascular systems (26) 26
clinical neurology (26) 26
electrochemistry (26) 26
follow-up studies (26) 26
física (26) 26
microbiology (26) 26
retrospective studies (26) 26
science (26) 26
zoology (26) 26
food science & technology (25) 25
health aspects (25) 25
physics, multidisciplinary (25) 25
chemistry, analytical (24) 24
classification (24) 24
nanoparticles (24) 24
risk (24) 24
chemotherapy (23) 23
disease (23) 23
endocrinology & metabolism (23) 23
genetics (23) 23
survival (23) 23
abridged index medicus (22) 22
computer simulation (22) 22
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Online Resources - Online (12) 12
Robarts - Stacks (7) 7
UTL at Downsview - May be requested (6) 6
Gerstein Science - Stacks (3) 3
Collection Dvlpm't (Acquisitions) - Closed Orders (2) 2
Collection Dvlpm't (Acquisitions) - Vendor file (2) 2
Engineering & Comp. Sci. - Stacks (1) 1
OISE - Curriculum Resources (1) 1
OISE - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1711) 1711
Italian (70) 70
French (14) 14
Portuguese (14) 14
German (4) 4
Latin (2) 2
Greek (1) 1
Russian (1) 1
Spanish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 25, pp. 2387 - 2397
In this trial, patients with an acute coronary syndrome within the previous 10 days were randomly assigned to simvastatin plus either ezetimibe or placebo. At... 
CHOLESTEROL ABSORPTION | CARDIAC OUTCOMES | MEDICINE, GENERAL & INTERNAL | MYOCARDIAL-INFARCTION | EFFICACY | CARDIOVASCULAR OUTCOMES | CLINICAL-TRIALS | SIMVASTATIN | PRIMARY PREVENTION | IMPROVE-IT | ATORVASTATIN | Simvastatin - therapeutic use | Double-Blind Method | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Azetidines - adverse effects | Ezetimibe | Kaplan-Meier Estimate | Male | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - drug therapy | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Azetidines - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Triglycerides - blood | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Cholesterol, LDL - blood | Female | Aged | Drug Therapy, Combination | Usage | Simvastatin | Analysis | Practice guidelines (Medicine) | Dosage and administration | Drug therapy, Combination | Acute coronary syndrome | Drug therapy | Myocardial infarction | Cerebral infarction | Lipoproteins (low density) | Stroke | Angina | Cholesterol | Intestine | Gallbladder | Acute coronary syndromes | Cardiovascular diseases | Statins | Pharmaceuticals | Cancer | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2018, Volume 379, Issue 22, pp. 2097 - 2107
Among patients who had had an acute coronary syndrome, the risk of death from coronary heart disease, nonfatal myocardial infarction, stroke, or unstable... 
MEDICINE, GENERAL & INTERNAL | MANAGEMENT | MYOCARDIAL-INFARCTION | TASK-FORCE | EFFICACY | SAFETY | LDL | REDUCING LIPIDS | PCSK9 | MONOCLONAL-ANTIBODY | ASSOCIATION | Double-Blind Method | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Hypercholesterolemia - drug therapy | Anticholesteremic Agents - adverse effects | Acute Coronary Syndrome - blood | Acute Coronary Syndrome - drug therapy | Acute Coronary Syndrome - complications | Anticholesteremic Agents - therapeutic use | Proprotein Convertase 9 - antagonists & inhibitors | Cardiovascular Diseases - epidemiology | Adult | Cholesterol, LDL - blood | Female | Hypercholesterolemia - complications | Aged | Acute coronary syndrome | Diagnosis | Myocardial infarction | Fees & charges | Lipoproteins (low density) | Heart attacks | Lipids | Cardiovascular disease | Angina | Apolipoprotein B | Ischemia | Heart diseases | Drug dosages | Statins | Cerebral infarction | Stroke | Subtilisin | Angina pectoris | Patients | Low density lipoprotein | Coronary artery disease | Cholesterol | Kexin | Monoclonal antibodies | Full text | Acute coronary syndromes | Cardiovascular diseases | Health risk assessment | Pharmaceuticals | Life Sciences | Human health and pathology | Cardiology and cardiovascular system
Journal Article